The COVID-19 Rapid Antigen Test Kit is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
COVID-19 Rapid Antigen Test Kits Market contains market size and forecasts of COVID-19 Rapid Antigen Test Kits in global, including the following market information:
- Global COVID-19 Rapid Antigen Test Kits Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global COVID-19 Rapid Antigen Test Kits Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five COVID-19 Rapid Antigen Test Kits companies in 2021 (%)
The global COVID-19 Rapid Antigen Test Kits market was valued at 28840 million in 2021 and is projected to reach US$ 5635.5 million by 2028, at a CAGR of -20.8% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fluorescence Immunochromatography Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of COVID-19 Rapid Antigen Test Kits include Abbott, Quidel, ACCESS BIO, CTK Biotech, SD Biosensor, Ellume, InBios, Celltrion and AESKU.GROUP, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the COVID-19 Rapid Antigen Test Kits manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Rapid Antigen Test Kits Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global COVID-19 Rapid Antigen Test Kits Market Segment Percentages, by Type, 2021 (%)
- Fluorescence Immunochromatography
- Colloidal Gold Immunochromatography
- Latex Immunochromatography
- Others
Global COVID-19 Rapid Antigen Test Kits Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global COVID-19 Rapid Antigen Test Kits Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Home
- School
- Third-Party Detection Institution
- Others
Global COVID-19 Rapid Antigen Test Kits Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global COVID-19 Rapid Antigen Test Kits Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies COVID-19 Rapid Antigen Test Kits revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies COVID-19 Rapid Antigen Test Kits revenues share in global market, 2021 (%)
- Key companies COVID-19 Rapid Antigen Test Kits sales in global market, 2017-2022 (Estimated), (M Units)
- Key companies COVID-19 Rapid Antigen Test Kits sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott
- Quidel
- ACCESS BIO
- CTK Biotech
- SD Biosensor
- Ellume
- InBios
- Celltrion
- AESKU.GROUP
- ROCHE
- BD
- OraSure Technologies
- Clip Health
- LumiraDx
- Princeton BioMeditech Corporation
- RapiGEN Inc.
- Orient Gene
- Wondfo Biotech
- Ihealth (Andon Health)
- Wantai BioPharm
- Biotest Biotech
- Shenzhen YHLO Biotech
- Vazyme Biotech
- EasyDiagnosis Biomedicine
- Beijing Hotgen Biotech
- Assure Tech
- Hangzhou AllTest Biotech
- ACON Biotech
- BGI Genomics
- Lepu Medical Technology
- Jinwofu Bioengineering Technology
- Phase Scientific
Industry Market Size
